Ethyl 1-benzoylpiperidine-4-carboxylate

Catalog No. :
ACVSWI876
CAS No. :
136081-74-8
Molecular Formula :
C15H19NO3
Molecular Weight :
261.32

IUPAC Name:ethyl 1-benzoylpiperidine-4-carboxylate

Ethyl 1-benzoylpiperidine-4-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$175.00Login to see priceInquiryInquiry
5g97%$486.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 1-benzoylpiperidine-4-carboxylate
IUPAC Nameethyl 1-benzoylpiperidine-4-carboxylate
MDL No.MFCD00667804
Molecular FormulaC15H19NO3
Molecular Weight261.32
SMILESO=C(C1CCN(C(C2=CC=CC=C2)=O)CC1)OCC
InChI KeyKZRCFZMHWBAFHJ-UHFFFAOYSA-N
Synonym1-Benzoyl-4-(ethoxycarbonyl)piperidine, Phenyl[4-(ethoxycarbonyl)piperidin-1-yl]methanone;1-Benzoyl-4-piperidinecarboxylic acid ethyl ester;Ethyl1-benzoylpiperidine-4-carboxylate97%;Ethyl 1-benzoylisonipecotate;1-Benzoyl-4-(ethoxycarbonyl)piperidine;Eficonazole Imp stage-I;4-Piperidinecarboxylic acid, 1-benzoyl-, ethyl ester
CAS No.136081-74-8
PubChem CID735824

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACVSWI876 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEXNQ621 route compound structure diagram
    ACEXNQ621147636-76-8 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVSWI876 route product structure diagram
    ACVSWI876136081-74-8
Inquiry

2. ACVSWI876 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEXNQ621 route compound structure diagram
    ACEXNQ621147636-76-8 In Stock
  2. Plus
  3. ACCSVD432 route compound structure diagram
    ACCSVD432532-31-0 In Stock
  4. Then
  5. ACVSWI876 route product structure diagram
    ACVSWI876136081-74-8
Inquiry

Comments (0)